GB1479934A - 1,3-oxygenated 8alpha-oestratrienes - Google Patents

1,3-oxygenated 8alpha-oestratrienes

Info

Publication number
GB1479934A
GB1479934A GB31241/74A GB3124174A GB1479934A GB 1479934 A GB1479934 A GB 1479934A GB 31241/74 A GB31241/74 A GB 31241/74A GB 3124174 A GB3124174 A GB 3124174A GB 1479934 A GB1479934 A GB 1479934A
Authority
GB
United Kingdom
Prior art keywords
compounds
oestratrienes
8alpha
oxygenated
oestraoligoene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31241/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of GB1479934A publication Critical patent/GB1479934A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
GB31241/74A 1973-07-13 1974-07-15 1,3-oxygenated 8alpha-oestratrienes Expired GB1479934A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (1)

Publication Number Publication Date
GB1479934A true GB1479934A (en) 1977-07-13

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31241/74A Expired GB1479934A (en) 1973-07-13 1974-07-15 1,3-oxygenated 8alpha-oestratrienes

Country Status (18)

Country Link
JP (1) JPS5821639B2 (en, 2012)
AT (1) ATA575574A (en, 2012)
AU (1) AU477010B2 (en, 2012)
CA (1) CA1030951A (en, 2012)
CH (2) CH614217A5 (en, 2012)
CS (2) CS182260B2 (en, 2012)
DD (1) DD114066A5 (en, 2012)
DK (1) DK133051C (en, 2012)
ES (1) ES428226A1 (en, 2012)
FI (1) FI54131C (en, 2012)
FR (1) FR2236505B1 (en, 2012)
GB (1) GB1479934A (en, 2012)
HU (1) HU169791B (en, 2012)
IE (1) IE39872B1 (en, 2012)
IL (1) IL45259A (en, 2012)
NO (1) NO742546L (en, 2012)
SE (1) SE7409151L (en, 2012)
SU (1) SU626705A3 (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119081B2 (en) 2000-08-18 2006-10-10 Sterix Limited Oestrogen-17-sulphamates as inhibitors of steroid sulphatase

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119081B2 (en) 2000-08-18 2006-10-10 Sterix Limited Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
US8030296B2 (en) 2000-08-18 2011-10-04 Sterix Limited Oestrogen-17-sulphamates as inhibitors of steroid sulphatase

Also Published As

Publication number Publication date
SU626705A3 (ru) 1978-09-30
AU7112374A (en) 1976-01-15
JPS5821639B2 (ja) 1983-05-02
IE39872B1 (en) 1979-01-17
IE39872L (en) 1975-01-13
DK368074A (en, 2012) 1975-03-17
FR2236505B1 (en, 2012) 1977-07-08
IL45259A0 (en) 1974-10-22
SE7409151L (sv) 1975-01-14
ES428226A1 (es) 1976-07-16
DK133051B (da) 1976-03-15
CH609064A5 (en) 1979-02-15
CS182260B2 (en) 1978-04-28
AU477010B2 (en) 1976-10-14
NO742546L (en, 2012) 1975-02-10
CA1030951A (en) 1978-05-09
HU169791B (en) 1977-01-28
DD114066A5 (en, 2012) 1975-07-12
DK133051C (da) 1976-08-16
ATA575574A (de) 1978-05-15
FI54131C (fi) 1978-10-10
FI54131B (fi) 1978-06-30
CH614217A5 (en) 1979-11-15
JPS5032160A (en, 2012) 1975-03-28
FI213974A7 (en, 2012) 1975-01-14
CS182300B2 (en) 1978-04-28
FR2236505A1 (en, 2012) 1975-02-07
IL45259A (en) 1977-10-31

Similar Documents

Publication Publication Date Title
GB1479934A (en) 1,3-oxygenated 8alpha-oestratrienes
ES373752A1 (es) Un procedimiento para la preparacion de nuevos derivados deisoxazol.
GB1530913A (en) Copying materials
ES428375A1 (es) Un procedimiento para preparar piperidinas disustituidas enlas posiciones 1 y 4.
ES425088A1 (es) Procedimiento para preparar resinas acidas.
ES436218A1 (es) Procedimiento para la obtencion de derivados de fenoxialca- nol.
GB1073272A (en) Process for the manufacture of amino-organosilanes
GB1209398A (en) Oxygenated decalin derivatives
ES392784A1 (es) Procedimiento para la preparacion de 3 beta - hidroxi - 5 alfa - cardenolidas y bufadienolidas.
ES432262A1 (es) Procedimiento de obtencion de eteres y esteres de la 3, 3- difenol-2-indolinona.
ES390920A1 (es) Procedimiento para la preparacion de 4,5 alfa - oxido - gufa-20,22-dienolid-3-(ramnosido 2'83' - dialcohilortocarbo-natos).
ES412799A1 (es) Un procedimiento para preparar alcoholes alcohilsulfonilme-tilbencilicos.
ES318808A1 (es) Procedimiento para la fabricacion de nuevos alcoholes terciarios
ES350667A3 (es) Procedimiento para la obtencion de barnices electroaislan- tes.
ES415611A1 (es) Un procedimiento para preparar una prostaglandina.
ES386351A1 (es) Un procedimiento para la preparacion de compuestos de 19- nortestosterona.
ES428016A1 (es) Un procedimiento para preparar nuevos aminoacidos.
GB1435892A (en) Aluminium complexes of guaiphenesin
ES370227A1 (es) Procedimiento para la preparacion de compuestos de triter- penoide.
ES344654A1 (es) Un procedimiento para la preparacion de un derivado de aci-do 3-indolilacetico.
ES428829A1 (es) Un procedimiento para la preparacion de una composiion de ester.
ES422607A1 (es) Un procedimiento para la preparacion de 13-etil-3-metoxi-8, 14-seco-gona-1,3,5(10), 8-tetraeno-17 beta-ol-14-ona racemi-ca.
GB1117456A (en) 1ªß-methyl-2,3ª‡-methylene steroids and a process for their manufacture
GB1433972A (en) Prostaglandin intermediates
GB1079083A (en) New methylene steroids

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee